Skip to content

ZO-Y49 PhaseIII clinical trial

ZO-Y49 PhaseIII clinical trial

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220729
Enrollment
Unknown
Registered
2009-05-08
Start date
2009-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease

Interventions

investigational material(s) Generic name etc : ZO-Y49 INN of investigational material : Therapeutic category code : 29- Other agents affecting individual organs Dosage and Administration for Investig

Sponsors

ZERIA Pharmaceutical Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Out patients who can understand the content of this trial and from whom a written informed consent to participate in this study can be directly obtained. In addition, in the case of patients whose age is less than 20 years old when the informed consent is obtained, the patients from whose representative a written informed consent must be obtained too.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety, Efficacy

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026